Food Supplement


18.00 16.20

Verrulix is a blend of Methionine and Minerals (Methiomineral complex™) with Zinc and Vitamin B6. Vitamin B6 contributes to normal function of the immune system and Zinc favours maintenance of normal skin.


Food Supplement, 30 film-coated tablets. Italian Parapharmaceutical Code: 913117851.

Verrulix contains Methionine, Magnesium, Vitamin B6, Zing, Iron and Manganese.

Methionine is an essential aminoacid with a methylated thiol group. Vitamin B6 contributes to normal function of the immune system, normal energy-yielding metabolism and normal protein metabolism. Magnesium has a role in the process of cell division and contributes to protein synthesis and normal energy-yielding metabolism. Zinc favours normal function of the immune system and maintenance of normal skin. Manganese contributes to normal metabolism and to protect the cells from oxidative stress. Iron helps normal function of the immune system.

The recommended dose is 2-3 tablets per day before meals. If needed tablets can be fragmented to facilitate swallowing.

Keep out of the reach of children under the age of 3. Do not exceed the recommended daily dose. Food supplements should not be intended or used as a substitute for a varied and balanced diet and a healthy lifestyle.

Chien XX, Zafra-Stone S, Bagchi M, Bagchi D., Bioavailability, antioxidant and immune-enhancing properties of zinc methionine. Biofactors. 2006;27(1-4):231-44. ;


Van Brummelen R, du Toit D., L-methionine as immune supportive supplement: a clinical evaluation. Amino Acids. 2007 Jul;33(1):157-63. ;


van Heugten E, Spears JW, Kegley EB, Ward JD, Qureshi MA., Effects of organic forms of zinc on growth performance, tissue zinc distribution, and immune response of weanling pigs. J Anim Sci. 2003 Aug;81(8):2063-71. ;


Gajula SS, Chelasani VK, Panda AK, Mantena VL, Savaram RR., Effect of supplemental inorganic Zn and Mn and their interactions on the performance of broiler chicken, mineral bioavailability, and immune response. Biol Trace Elem Res. 2011 Feb;139(2):177-87

You may also like…